There are multiple applications of nuclear magnetic resonance (NMR) spectroscopy across a variety of industries. This powerful analytical technique has been used to study the structure of molecules, and the interactions between them for the past 60 years. Its broad range of uses in the pharmaceutical, biomedical, food science and many other industries make NMR an invaluable tool. This white paper focuses on a relatively new capability of NMR; monitoring reactions in real-time.

Researchers have developed what could be a much more patient-friendly option for those with type 1 and 2 diabetes: artificial cells that automatically release insulin into the bloodstream when glucose levels rise.

A University of Maryland-led study developed a vaccine candidate that spurs animals to produce antibodies against protective sugars of multiple HIV strains.

A new family of multichannel electronic pipettes is closing the gap between traditional manual pipettes and robotic systems. This new video will provide you with an informative insight into how to improve your biological sample processing and collection.

Scientists are altering a powerful gene-editing technology in hopes of one day fighting diseases without making permanent changes to people's DNA. The trick: Edit RNA instead, the messenger that carries a gene's instructions.

DNA Damage is ceaseless. The latest in DNA Damage/Genotoxicity Kits, detects seven proteins in this pathway, including important phosphorylation changes. This white paper demonstrates the utility in two cancer cell lines in which all analytes were detected with good specificity, sensitivity and precision.

An international team of researchers led by the University of Adelaide has published the full genome of the water buffalo - opening the way for improved breeding and conservation of this economically important animal.

Seventy-two new genetic variants that contribute to the risk of developing breast cancer have been identified by a major international collaboration involving hundreds of researchers worldwide.

This application note explores a robust, simple evaporative sample preparation method that improves the ability to analyze typical levels of these molecules in water samples.

1ST Biotherapeutics, Inc., a private Korean biotech company, and Neuraly Inc., a startup from Johns Hopkins School of Medicine, today announced a collaboration to co-develop novel brain penetrant c-Abl inhibitors for Parkinson's disease. Recent research has shown that inhibitors to c-Abl could slow the progression of Parkinson's disease.